Skip to main content

Table 1 Baseline characteristics of the cohort, overall and by hepatitis C virus (HCV) status

From: Low prevalence of hepatitis C co-infection in recently HIV-infected minority men who have sex with men in Los Angeles: a cross-sectional study

Characteristic Total (N = 185) na (%) or median (IQR) HCV negative (N = 182) na (%) or median (IQR) HCV positive (N = 3) na (%) or median (IQR)
Sociodemographics
 Age (years) 28.3 (24.7–35.0) 28.3 (24.7–34.8) 35.8 (22.3–45.1)
Race
 African American 32 (17.7) 31 (17.4) 1 (33.3)
 Hispanic 89 (49.2) 87 (48.9) 2 (66.7)
 White 47 (26.0) 47 (26.4) 0 (0)
 Asian 5 (2.8) 5 (2.8) 0 (0)
 Other 8 (4.4) 8 (4.4) 0 (0)
Incarcerated, past 12 months 17 (9.3) 17 (9.5) 0 (0)
Substance Use, past 3 months
 Any drugs (including cannabis) 96 (52.8) 93 (52.0) 3 (100)
 Cannabis 79 (43.4) 77 (43.0) 2 (66.7)
 Cocaine 26 (14.3) 25 (14.0) 1 (33.3)
 Methamphetamine 33 (18.1) 30 (16.8) 3 (100)
 Inhalants 6 (3.3) 5 (2.8) 1 (33.3)
 Sedatives 16 (8.8) 15 (8.4) 1 (33.3)
 Hallucinogens 3 (1.7) 2 (1.1) 1 (33.3)
 Opioids 6 (3.3) 5 (2.8) 1 (33.3)
Injection drug use, past 12 months 12 (6.6) 11 (6.2) 1 (33.3)
Partner injection drug use, past 12 months 34 (18.6) 32 (17.8) 2 (66.7)
Alcohol use, past 3 months 129 (70.9) 127 (71.0) 2 (66.7)
Sexual Behaviors
 Sexual partners, past 12 months 9 (4–20) 9 (4–20) 6 (6–14)
 Unprotected insertive AI, last 6 partners 115 (64.6) 113 (64.2) 2 (66.7)
 Unprotected receptive AI, last 6 partners 132 (74.6) 130 (74.3) 2 (66.7)
 Fisted by partner, last 6 partners 10 (5.7) 10 (5.8) 0 (0)
 Transactional sex 20 (11.0) 19 (10.6) 1 (33.3)
 Group sex 60 (33.3) 58 (32.4) 2 (66.7)
Sexually Transmitted Infections
 Chlamydia, baseline testing 32 (18.2) 30 (17.3) 2 (66.7)
 Gonorrhea, baseline testing 19 (10.6) 19 (10.8) 0 (0)
 Syphilis, TPPA positive, baseline testing 47 (27.5) 46 (27.2) 1 (33.3)
 Chlamydia, self-reported, past 12 months 69 (37.9) 68 (38.0) 1 (33.3)
 Gonorrhea, self-reported, past 12 months 65 (35.7) 64 (35.8) 1 (33.3)
 Syphilis, self-reported, past 12 months 57 (31.3) 56 (31.3) 1 (33.3)
 HSV, self-reported, past 12 months 11 (6.0) 11 (6.2) 0 (0)
HIV viral load, copies/mLb 41,538 (5771–150,756) 41,518 (6296–144,378) 60,476 (<50–155,000)
CD4 cell count (cells/mm3)c 553 (408–692) 553 (408–692) Unavailable
  1. IQR interquartile range, AI anal intercourse, TPPA treponema pallidum particle agglutination, HSV herpes simplex virus
  2. aSum of n may not equal total N because of missing data; bAvailable for 171 of 185 subjects; cAvailable for 80 subjects